IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Gujarat Kidney And Super Speciality IPO is a book build IPO listing on BSE,NSE exchange. The company is based in Vadodara and caters to Advertising And Media sector. Nirbhay Capital Services Private is the merchant banker of Gujarat Kidney And Super Speciality IPO. It is a MAINBOARD UPCOMING IPO which filed its Draft Red Herring Prospectus (DRHP) on 28th March 2025.
Gujarat Kidney And Super Speciality IPO posted revenues of Rs 37.34 crores and PAT of Rs 11.26 crores in FY25 on annualised basis.Financial results of Gujarat Kidney And Super Speciality IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Gujarat Kidney And Super Speciality IPO PAT Margin is 30.16%, ROCE (Return on Capital Employed) is 26.73% as per latest financial. The below table shows Gujarat Kidney And Super Speciality IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Gujarat Kidney And Super Speciality IPO is Rs [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Gujarat Kidney And Super Speciality IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Gujarat Kidney And Super Speciality IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Gujarat Kidney And Super Speciality IPO is ₹[●] Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Gujarat Kidney And Super Speciality IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Gujarat Kidney And Super Speciality IPO reported revenue of ₹37.34 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Gujarat Kidney And Super Speciality IPO provide insights into sales growth, market demand, and business scalability.
Gujarat Kidney And Super Speciality recorded an EBITDA of ₹ 18.68 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Gujarat Kidney And Super Speciality Profit After Tax (PAT) is ₹11.26 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 37.34 Cr.
EBITDA Margin:
50.03
%
Net Worth: ₹ 20.61 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: [●]
Gujarat Kidney And Super Speciality operates in Advertising And Media and Regional Healthcare Companies Located In The Central Region Of State Of Gujarat And Operate A Chain Of Mid-sized Multispeciality Hospitals. The Issue is listed on BSE,NSE in Apr, 2025. Gujarat Kidney And Super Speciality IPO size was with Issue price of .
Merchant Banker(s) of Gujarat Kidney And Super Speciality IPO: Nirbhay Capital Services Private Limited
Gujarat Kidney And Super Speciality IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Gujarat Kidney And Super Speciality IPO listed at a listing price of against the offer price of .
The current market price of Gujarat Kidney And Super Speciality is .
Why Us?
